Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC)-Reference-Cited by-同舟云学术

Idiotype vaccination in patients with myeloma reduced circulating myeloma cells (CMC)

Published:2008-06 Issue:6 Volume:19 Page:1172-1179
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Abdalla A.O.,Kokhaei P.,Hansson L.,Mellstedt H.,Österborg A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/19/6/1172/372615/mdn017.pdf

Reference32 articles.

1. Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas;Corradini;J Exp Med,1993

2. Clonotypic B cells in the peripheral blood of patients with multiple myeloma;Cremer;Blood,2001

3. Multiple myeloma, Waldenström's macroglobulinemia and benign monoclonal gammopathy. Characteristics of the B cell clone, immunoregulatory cell populations and clinical implications;Mellstedt;Adv Cancer Res,1984

4. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma;Pilarski;Blood,1994

5. Multidrug resistance of a continuously differentiating monoclonal B lineage in the blood and bone marrow of patients with multiple myeloma;Pilarski;Curr Top Microbiol Immunol,1992

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bortezomib promotes apoptosis of multiple myeloma cells by regulating HSP27;Molecular Medicine Reports;2019-07-03

2. Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells;PLOS ONE;2018-02-12

3. Anti-Idiotype Antibodies;Cancer Therapeutic Targets;2017

4. Challenges in vaccine therapy in hematological malignancies and strategies to overcome them;Expert Opinion on Biological Therapy;2016-06-13

5. Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia;PLOS ONE;2015-11-12